Interventional Cardiology Device Market Size, Share, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) – Market Trends, Analysis and Forecast till 2034

Interventional cardiology devices Market Size was valued at US$ 17.0 billion in 2024 and is projected to grow at a CAGR of 17.0%to reach US$ 71.3 billion by 2034.

Interventional cardiology (IC) is flexible, specially designed catheters are used to perform non-surgical diagnostics, treatments, and operations. These minimally invasive procedures are carried out in a hospital in the Cath Lab, also known as the cardiac catheterization lab.
An interventional cardiologist uses an IC technique to access the heart and blood vessels in order to diagnose or treat a cardiac disease. The cardiologist inserts a small, flexible catheter into an artery in the groin. During the process, real-time images of the patient's heart and arteries are obtained using fluoroscopy imaging equipment.

The surgery can take anywhere from 30 minutes to several hours, and most patients can return home the same day. The recuperation period usually lasts between 4 and 8 hours.
To ascertain the next stages in a treatment plan, a cardiac catheterization procedure may be performed just for diagnostic purposes. The patient may have light sedation, general anaesthesia, or be awake but receive medicine to help them relax throughout this surgery. This process is used to find artery constriction or blockages, check for blood clots, diagnose valve problems, and measure the pressure inside the heart's chambers.

A few of these operations include trans catheter valve replacement and repair, cardiac biopsy, cardiac ablation to restore normal electrical rhythms, angioplasty to widen narrow arteries, stent or balloon implantation to open narrow arteries and valves, and closure and clip device implantations.
Heart-related illnesses are the world's largest cause of mortality; in the United States alone, coronary heart disease claims the lives of over 360,000 individuals each year. The two largest risk factors for coronary heart disease are diabetes and hypertension. With a projected 700 million diabetes sufferers by 2045, the global incidences of the disease are startling. Another factor contributing to the rise in cardiovascular healthcare requirements is the aging population. The diagnostic techniques are frequently followed by additional therapeutic procedures.

Interventional cardiology devices Market Drivers:   

The prevalence of cardiovascular diseases (CVDs) is on the rise

• Heart failure, arrhythmias, and coronary artery disease (CVD) are the world's top causes of death. Growing knowledge of CVDs, bad lifestyles (smoking, poor food, inactivity), and aging populations all drive up demand for interventional procedures and the technologies that support them.

Technological Progress

• More efficient and less invasive interventional devices are being developed as a result of market’s ongoing innovation:
• Stents: Patients can benefit for a long time from newer stents, such as drug-eluting stents that release medication to prevent re-blockages.
  Balloon catheters: New developments in balloon technology enable better blood flow restoration and more accurate operations.
• Catheter-based valve replacements: Less invasive alternatives to open heart surgery are provided by methods such as Transcatheter Aortic Valve Replacement (TAVR).
• Robotic-assisted interventions: As robotics becomes more prevalent, it can help achieve more control and precision in treatments.

Increasing Attention to Less Invasive Techniques

• Because of the following benefits, minimally invasive procedures are preferred by both patients and healthcare providers:
• Reduced healthcare expenses and a quicker return to regular activities for patients are the results of quicker recovery times and shorter hospital stays.
• Decreased discomfort and agony: Compared to open cardiac surgery, minimally invasive techniques typically cause less pain and discomfort.
  Better patient outcomes: New methods and technologies enable safer, more effective operations with fewer problems.

Restrains in the Interventional cardiology devices Market:

Exorbitant Cost of Equipment and Procedures

• Interventional cardiology devices can be quite costly, especially catheter-based valve replacements and sophisticated stents. Accessibility issues may arise from this high cost, particularly in underdeveloped nations with constrained healthcare resources.
  High out-of-pocket expenses for patients with insurance can discourage them from undergoing surgeries that need these devices, even in industrialized nations.

Key Opportunities in Interventional cardiology devices Market:

Creation of Upcoming Electronic Devices

• Biodegradable Stents: These stents fall out naturally over time, thus removing them doesn't require additional surgery.
  Advanced Catheter Technologies: More accurate treatments and access to intricate anatomy will be possible with the help of more recent catheters that are more flexible and manoeuvrable.
  Robotic-Assisted Interventions: As robotics continues to progress, more control, accuracy, and maybe faster procedure times will be available.

Pay Attention to Less Invasive Methods

• Opportunities for less intrusive procedures are created by the increased need for:
  The creation of increasingly more advanced and tiny devices will make it possible to reach blood veins that are smaller and may lower the risk of complications.
  Procedures performed on an outpatient basis could be more accessible to patients as they grow less invasive, which would save healthcare costs and enhance patient convenience.

Interventional cardiology devices Market is segmented based on based on By Type, Deployment Mode, Application, End-User and Region.

By Type

• Angioplasty Balloons- These expandable catheters are used to open up constricted arteries, enhancing the heart's blood supply.
• Angioplasty Stents- After balloon angioplasty, small mesh tubes are put into the arteries to keep them open and stop re-narrowing.
• Catheters – A broad category that includes different sheaths and guide wires that are used to thread through blood vessels during medical procedures.
• Plaque Modification Devices – These tools, such as atherectomy tools, aid in clearing or dissolving plaque accumulation in arteries before to or after angioplasty.
• Hemodynamic Flow Alteration Devices – By controlling blood flow within the heart chambers, these devices, such atrial septal defect (ASD) closure devices, are used to treat particular heart problems.
• Others - This section contains a range of specialist equipment for treatments such as peripheral artery interventions, tran’s catheter aortic valve replacement (TAVR), and mitral valve repair.

Interventional cardiology devices Market Regional Insights:

On region the Interventional cardiology devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America a developed market that spends a lot on healthcare and has embraced cutting-edge technology. Because of the region's well-established infrastructure, strong reimbursement rules, and high prevalence of CVDs, it holds a dominant market share. Cost-cutting strategies are becoming more and more important, though.
• Asia Pacific region is the market with the quickest rate of growth, because to government healthcare efforts, a big and aging population, and rising disposable incomes. There are a lot of chances in this region for producers of affordable equipment.
• Europe a seasoned market with strict laws and an emphasis on quality. The market is anticipated to grow steadily, and reimbursement policies may be complicated.
• Latin America is a burgeoning market where demand for reasonably priced interventional cardiology equipment is rising along with healthcare investments. Building up the infrastructure and training doctors are still essential components of growing the business.
• Middle East & Africa region is with great promise because of the expanding healthcare infrastructure and the rising incidence of CVDs. On the other hand, there are obstacles due to underdeveloped healthcare systems, smaller disposable resources, and restricted access to cutting edge technologies.

Interventional cardiology devices Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Interventional cardiology devices Market report based on By Type and Region:

Interventional cardiology devices Market, By Types:

• Angioplasty
•  Balloons
•  Angioplasty Stents
•  Catheters
• Plaque Modification Devices
•  Hemodynamic Flow Alteration Devices
• Others

Interventional cardiology devices Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Interventional cardiology devices Market includes, Cordis Corporation, Abbott Laboratories, Medtronic, Inc., Terumo Medical Corporation, Braun Melsungen AG, Boston Scientific Coprporation, Terumo Corporation, Biosensors International Group, Ltd., and Biotronik, Inc.

• In February 2024, US launched the Micro Rx catheter by Biotronik Interventional Medical Device Solutions is the manufacturer of the Micro Rx quick exchange microcatheter. A novel tool for improving guidewire support during percutaneous coronary interventions (PCI) has been introduced by Biotronik in the United States: The Micro Rx catheter. Biotronik is the only distributor of the quick exchange microcatheter, which is manufactured by Interventional Medical Device Solutions (IMDS). With a core wire sandwiched between two layers of braiding, the Micro Rx catheter's strengthened distal shaft provides ideal push transmission.
• In February 2024, in a move toward radiation-free interventional imaging, Philips Healthcare launched the limited introduction of a novel light-based catheter guidance system for Cath laboratories. As of right now, endovascular aortic procedures are the main focus of technology. As a further step to collect more clinical data on its performance, the company announced that specialized hospitals in Europe and the US will be allowed to use its new Lumi Guide system. The solution will then be made available on a worldwide scale.
• On June 11, 2024, The Mitral and Tricuspid Centre, an advanced clinical research centre devoted to utilizing the knowledge of specialists from various cardiovascular disciplines to improve the diagnosis and treatment of all types of tricuspid and mitral valve conditions, has been launched by the CUIMC Division of Cardiology at Columbia University Irving Medical Centre.

• Cordis Corporation

• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview

• Abbott Laboratories
• Medtronic, Inc.
• Terumo Medical Corporation
• Braun Melsungen AG
• Boston Scientific Coprporation
• Terumo Corporation
• Biosensors International Group, Ltd.
• Biotronik, Inc.

“*” marked represents similar segmentation in other categories in the respective section.